UPM annual report 2015
IN BRIEF
STRATEGY
BUSINESSES
STAKEHOLDERS
GOVERNANCE
ACCOUNTS
Consolidated cash flow statement
Notes to the consolidated financial statements (In the notes all amounts are shown in millions of euros unless otherwise stated.)
1 Accounting policies
and the equity instruments issued at the acquisition date. The consider- ation transferred includes the fair value of any assets or liabilities result- ing from a contingent consideration arrangement. Transaction costs related to an acquisition are expensed as incurred. Identifiable assets acquired and liabilities and contingent liabilities assumed in a business combination are measured initially at their fair values at the acquisition date. For each business combination, the Group measures any non- controlling interest in the acquiree either at fair value or at the non-con- trolling interest's proportionate share of the acquiree's net assets. The excess of the consideration transferred, the amount of any non- controlling interest in the acquiree and the acquisition-date fair value of any previous equity interest in the acquiree over the fair value of the identifiable net assets of the subsidiary acquired is recorded as good- will. If this is less than the fair value of the net assets of the subsidiary acquired in the case of a bargain purchase, the difference is recog- nised directly in the income statement (see below “Intangible assets” for goodwill accounting policy). Subsidiaries are fully consolidated from the date on which control is transferred to the Group and are no longer consolidated from the date when control ceases. All intercompany transactions, receivables, liabilities and unre- alised profits, as well as intragroup profit distributions, are eliminated. Unrealised losses are also eliminated unless the transaction provides evidence of an impairment of the asset transferred. Accounting policies of subsidiaries have been changed where necessary to ensure consis- tency with the policies adopted by the Group. When the Group ceases to have control in subsidiary, any retained interest in the entity is remeasured to its fair value, with the change in carrying amount recognised in income statement. Joint operations A joint operation is a joint arrangement whereby the parties that have joint control of the arrangement have rights to the assets and obliga- tions for the liabilities, relating to the arrangement. Joint control is the contractually agreed sharing of control of an arrangement, which exists only when decisions about the relevant activities require unani- mous consent of the parties sharing control. The Group accounts in relation to its interest for the assets, liabili- ties, revenues and expenses related to a joint operation in accordance with IFRS applicable for the particular item. Transactions with joint operations are recognised in the consolidated financial statements only to the extent of other parties’ interests in the joint operation. Associated companies and joint ventures Associated companies are entities over which the Group has signifi- cant influence but no control, generally accompanying a shareholding of between 20% and 50% of the voting rights. Joint ventures are joint arrangements whereby the parties that have joint control of the ar- rangement have rights to the net assets of the joint arrangement. Interests in associated companies and joint ventures are accounted for using the equity method of accounting and are initially recognised at cost. Under this method the Group’s share of the associated com- pany and joint venture profit or loss for the period is recognised in the income statement and its share of movements in other comprehensive income is recognised in other comprehensive income. The Group’s interest in an associated company and joint venture is carried on the balance sheet at an amount that reflects its share of the net assets of the associated company and joint venture together with goodwill on acquisition (net of any accumulated impairment loss), less any impair- ment in the value of individual investments. Unrealised gains and losses on transactions between the Group and its associates and joint ventures are eliminated to the extent of the Group’s interest in the asso- ciated company and joint venture, unless the loss provides evidence of an impairment of the asset transferred. Associated company and joint
Year ended 31 December
2015
2014
EURm
Note
The principal accounting policies applied in the preparation of the consolidated financial statements are set out below: Principal activities UPM-Kymmene Corporation (“the parent company” or “the company”) together with its consolidated subsidiaries (“UPM” or “the Group”) is a global paper and forest products group, mainly engaged in the pro- duction of paper, with an emphasis on the manufacture and sale of printing and writing papers. UPM reports financial information for the following business areas (segments): UPM Biorefining, UPM Energy, UPM Raflatac, UPM Paper Asia, UPM Paper ENA, UPM Plywood and Other operations. The Group’s activities are centred in European Union countries, North and South America and Asia with production plants in 13 countries. UPM-Kymmene Corporation is a Finnish limited liability company, domiciled in Helsinki in the Republic of Finland. The address of the company’s registered office is Alvar Aallon katu 1, 00100 Helsinki, where a copy of the consolidated financial statements can be obtained. The parent company is listed on NASDAQ OMX Helsinki Ltd. These Group consolidated financial statements were authorised for issue by the Board of Directors on 2 February 2016. According to the Finnish Companies Act, the General Meeting of Shareholders is enti- tled to decide on the adoption of the company’s financial statements. Basis of preparation These consolidated financial statements of UPM are prepared in accor- dance with International Financial Reporting Standards as adopted by the European Union (IFRS as adopted by the EU) and IFRIC Interpreta- tions. The consolidated financial statements have been prepared under the historical cost convention, except for biological assets, available- for-sale investments and certain other financial assets and financial liabilities, defined benefit plan assets and obligations and share-based payment arrangements. The preparation of financial statements requires the use of account- ing estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. Accounting esti- mates are employed in the financial statements to determine reported amounts, including the realisable value of certain assets, the useful lives of tangible and intangible assets, income tax and other items. Although these estimates are based on management’s best knowledge of current events and actions, actual results may ultimately differ from them. The preparation of financial statements also requires manage- ment to exercise its judgement in the process of applying the Group’s accounting policies. The most significant critical judgements are sum- marised in Note 2. Consolidation principles Subsidiaries The consolidated financial statements of UPM include the financial statements of the parent company, UPM-Kymmene Corporation, and its subsidiaries. Subsidiaries are those entities in which the Group has control. The Group has control over an entity if it has power over the entity; it is exposed or has rights to variable returns from its involve- ment with the entity and has the ability to use its power to affect the amount of its returns from the entity. Business combinations are accounted for by using the acquisition method of accounting. The consideration transferred in a business com- bination is the fair value of the assets transferred, the liabilities incurred
Cash flow from operating activities Profit (loss) for the period
916 449
512 779
Adjustments
5
Interest received
6
7
Interest paid
–22
–40
Dividends received
1
2
Other financial items, net
–17
–11 –81
Income taxes paid
–140
Change in working capital
5
–8
73
Net cash generated from operating activities
1,185
1,241
Cash flow from investing activities Capital expenditure
–432
–378
Acquisition of shares in associated companies and joint ventures
–1
–1
Acquisition of available-for-sale investments Proceeds from sale of tangible and intangible assets
–33
–31
26
89
Proceeds from disposal of subsidiaries
5
8
1
Proceeds from disposal of available-for-sale investments
35
68
Change in other non-current assets Net cash used in investing activities
5
5
–392
–247
Cash flow from financing activities Proceeds from non-current liabilities Payments of non-current liabilities
22
–
–519
–836
Change in current liabilities Share options exercised
22
34 47
–
Dividends paid
–373
–319
Other financing cash flow
–20
–22
Net cash used in financing activities
–868
–1,096
Change in cash and cash equivalents
–75
–102
Cash and cash equivalents at beginning of period Foreign exchange effect on cash and cash equivalents
700
787
1
15
Change in cash and cash equivalents
–75 626
–102
Cash and cash equivalents at end of period
700
The notes are an integral part of these consolidated financial statements.
contents
accounts
93
94
UPM Annual Report 2015
UPM Annual Report 2015
Made with FlippingBook